patrick.net

💉💉 First up, for comic relief, behold the latest news on the Pfizer cancer shot. Yesterday’s over-enthusiastic headline from Futurism Magazine broadcast:




No thanks! I would rather inject myself with bleach. Into my eyeball. With a bent needle I found on the sidewalk in downtown San Fransisco.

So much to mock, so little time. The cowardly jab maniacs at Pfizer are conducting their mRNA trials in unaware England — which mostly missed out on the bizarre mRNA bonanza, since for most of the early years the English used a mad formula cooked up in Great Britain and now recalled.

U.S. — Pfizer CEO Albert Bourla addressed public concerns over a new pandemic by holding a press conference in which he explained how the pharmaceutical company is already hard at work developing a new ineffective vaccine with fatal side effects.

"The thought of a new pandemic is scary, especially one that presents as a common cold and makes you really tired," said Bourla. "That's why we're working double time to prepare a new vaccine that won't cure you, but will possibly kill you."

"We have top scientists working around the clock to ensure it doesn't work before we release it to the public."

Later, he agreed to appear on CNN This Morning for what he originally assumed was a softball interview. Host Kasie Hunt was quick to point out the obvious concern with Pfizer's business model. "But sir, how can you possibly prepare an ineffective vaccine in advance of an unknown pandemic? You don't know what the virus will be."

In response, Bourla appeared to side-eye the camera before awkwardly fidgeting in his seat and changing the subject. "We make lots of money," he said. "Would you like some?"

Pfizer hit an intraday 52 week low on Friday.

The novel’s plot was reminiscent of a controversial drug trial performed by Pfizer in Kano, Nigeria in 1996 during a meningococcal outbreak. For the trial of its new antibiotic, trovafloxacin, Pfizer gave 100 children this new drug. The control group of 100 other children received the standard anti-meningitis treatment at the time—a drug called ceftriaxone. However, for the control group, Pfizer administered a substantially lower dose of ceftriaxone than the drug’s FDA-approved standard.

When the reduced dosing in the control group was discovered, it raised the suspicion that Pfizer did this in order to skew the trial in favor of its new drug. Five of the children who received trovafloxacin died, while six who received the reduced dose of ceftriaxone died. Other children apparently suffered grave injuries from the administration of the experimental antibiotic without their informed consent. The investigation and litigation that ensued was the stuff of a thriller, involving private investigators, bribery, blackmail attempts, and disappearing records. Thirteen years later, in 2009, Pfizer settled out of court with the plaintiffs. ...

In 2009, the same year that Pfizer settled with the trovafloxacin plaintiffs, the New York Times reported that a U.S. federal judge assessed Pfizer with the “largest health care fraud settlement and the largest criminal fine of any kind ever” for its illegal marketing of Bextra and three other drugs. The U.S. Department of Justice was unequivocal in characterizing Pfizer’s officers as guilty of grave criminal conduct at the expense of the American public.

As I have long known all of the above, I wasn’t surprised by the gross criminal conduct revealed in The Pfizer Papers: Pfizer’s Crimes Against Humanity, edited by Naomi Wolf with Amy Kelly and a Foreword by Stephen K. Bannon. ...

The book strikes me as one of the most impressive works of investigative scholarship in history. As Dr. Peter McCullough described it in his Praise (printed on the book’s first page):

"This is a comprehensive, organized, and compelling presentation of vaccine safety data that has accumulated after mass and indiscriminate administration of the Pfizer mRNA COVID-19 vaccines. Sadly, a large group of vaccine recipients have become injured, disabled, and many have died after the ill-advised injections. The data with histopathological evaluation at necropsy and autopsy with expert analysis is presented so you can evaluate it for yourself. Never before has there been a class of products with this wide range and extended duration of injury to the recipient."